U.S. to exempt UK pharmaceuticals and ingredients under trade deal

The United States government announced Monday that it will exempt pharmaceuticals, pharmaceutical ingredients, and medical‑technology products originating from the United Kingdom from current and future U.S. tariffs as part of a newly negotiated trade agreement in principle.